Transforming M&A – The Lasting Impact Of COVID-19 And The CARES Act

Our M&A Master Class Series has been thoughtfully designed to highlight critical topics and legal implications throughout the life cycle of a transaction. We look forward to continuing this important dialogue through events and other communications in 2021.

Today’s mergers and acquisitions environment has grown significantly more complex based on the influence of novel events in 2020, most notably, the Coronavirus (COVID-19) and the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). As a […]

By | Jan 21, 2022 ||

What Are My Exit Options As A Public Benefit Corporation?

n our March 25, 2019 article for VC Experts, “Can I Raise Venture Capital as a Public Benefit Corporation?” we described society’s rising expectation that corporations, large and small, should generate positive social impact alongside profits.1 More than a year and half later—in the face of a global pandemic, unprecedented economic downturn and a heightened focus on defeating systemic inequality—this trend has only accelerated. Executives and boards are making business decisions not just for the benefit […]

By | Jan 19, 2022 ||

Private Equity Deals Face More Antitrust Scrutiny Under Proposal

Vishal Mehta spoke to Bloomberg Law about a proposed rule from the Federal Trade Commission and the Justice Department’s Antitrust Division that would expand the meaning of a “person” that must report a transaction for antitrust review under the Hart-Scott-Rodino Act to now include the acquiring company’s associated entities, such as affiliates.

“This would add an additional layer of analysis in determining whether a filing is required, and it would potentially increase and lead to additional reportable […]

By | Jan 17, 2022 ||